Ratings EHR RESO Australian S.E.

Equities

End-of-day quote Australian S.E. Other stock markets			5-day change	1st Jan Change
- ^AUD	-.--%		-.--%	-.--%

05-16	Burgundy Diamond Mines to Commence Delineation Drilling Program at Sable Underground Project	MT
04-30	Euroz Hartleys Adjusts Burgundy Diamond Mine’s Price Target to AU$0.65 From AU$0.63, Keeps at Speculative Buy	MT

Its low valuation, with P/E ratio at 1.5 and 1.24 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
Over the past four months, analysts' average price target has been revised downwards significantly.

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
EHR RESO	-.--%	156M	-	-
ALROSA	-.--%	5.42B	-	C-
LUCARA DIAMOND CORPORATION	-11.69%	116M	-	B-
PETRA DIAMONDS LIMITED	-40.14%	107M		A-

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality